CNBC
| January 23, 2013
Aegerion CEO on Promise of Biopharma
Marc Beer, Aegerion Pharmaceuticals CEO, discusses a drug in the company's pipeline that treats patients with severe cholesterol disorder.
Sorry, we do not have a transcript available for this video at this time.